Skip to main content
GKOS logo

GKOS · GLAUKOS Corp

Track GKOS — free
$184.53 -4.92 (-2.60%) At close · Aug 14
Market Cap
$10.88B
Shares
58.98M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$184.53 Open$189.89 Day$184.22–190.00 52W close$74.67–189.45 Avg vol 30d835K Short int3.6M · 6.1% float · 3.6d Short vol56% Last earningsJul 29, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 29, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +51%
      above
      Price vs 50-day avg +23%
      above
      RSI (14) 74
      overbought
      MACD trend Positive
      52-week position 96%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +18%
      trailing
      6-month return +53%
      trailing
      YTD return +63%
      this year
      Relative strength +39%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $151 › 200d $122 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +66 funds added
      Insider flow Distributing
      Net -$10.9M over 90 days · 100% sells
      Short interest Falling
      6.15% of float · ▼ -22.9% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      362 holders — near 3-yr high, broad support
      Squeeze score 57
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +32%
      Y/Y
      Gross margin 56%
      contracting
      EPS growth −18%
      Y/Y
      Free cash flow $-22.5M
      Balance sheet $81.1M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 53%
      annualized · 1-yr
      Max drawdown −28%
      past year
      ATR 3.7%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 29, 2026
      Net sales · 2026 $680M – $700M
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Net sales · full year 2025 $490M – $495M
      Guided vs delivered · last 1 settled
      Full-year 2024 net sales full-year 2024
      guided $350M – $360M
      $383.48M Beat +8.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +51% Bullish
      Price vs 50-day avg
      +23% Bullish
      RSI (14)
      74 Bearish
      MACD trend
      Positive Bullish
      52-week position
      96% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $151 › 200d $122 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +66 funds added
      Insider flow Distributing
      Net -$10.9M over 90 days · 100% sells
      Short interest Falling
      6.15% of float · ▼ -22.9% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      362 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $75 Now $185 · 96% Range high $189
      vs 200-day avg +51% vs 50-day avg +23%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Non-GAAP net loss per diluted share non-GAAP -$0.14 Q2 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      GKOS
      GLAUKOS Corp
      this stock
      $10.88B +63.4% +32.3% 6.1%
      ABT
      Abbott Laboratories
      $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      362
      % held
      104.6%
      Net QoQ
      +2.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      405
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.6M
      Days to cover
      3.6d
      Change
      -1.1M sh
      View
      Short Volume
      Short vol %
      56%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      44
      Value
      $6.8K
      As of
      Jul 10, 2026
      View
      Off-Exchange
      Off-exchange %
      46.7%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$10.9M
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $507.4M
      Net income (FY)
      $-187.7M
      EPS diluted
      $-3.28
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 3, 2026
      This year
      16
      View
      Proposed Sales
      Value
      $10.8M
      Shares
      60.0K
      Filed
      Aug 11, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 29, 2026
      View
      Investor Relations
      Latest news
      Glaukos Announces Second Quarter…
      Published
      Jul 29, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      GKOS +2.5% +17.7% +53.3% +10.7% +63.4%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +2.1% +13.2% +39.5% +6.8% +49.6%
      Key facts CIK 1192448 CUSIP 377322102 13F (30d) 336 filings 336 filers Visit website Investor relations